In the GSE7621 internal validation cohort, the expression of EN1 and LOXL1 was lower, while the expression of IRF7 and PLOD3 was higher in PD tissues than in normal controls (Figure 6A). The gene discussed is LOXL1; the disease is Parkinson disease.